基胺向MDH2通过代谢调节的表观遗传修饰来缓解衰老的表型
Zhifan Mao1, Wenwen Liu2, Rong Zou1
1State Key Laboratory of Bioreactor Engineering, Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Frontiers Science Center for Materialbiology and Dynamic Chemistry, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Signal transduction and targeted therapy
|February 17, 2025
概括
线粒体酸脱酶 (MDH2) 抑制通过改变新陈代谢和表观遗传修饰来减缓衰老. 药物glibenclamide (Gli) 通过向MDH2,延长寿命和减少小鼠的脆弱性,显示出抗衰老作用.
科学领域:
- 生物化学 生物化学
- 老年学是一门学科.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 线粒体代谢影响衰老和表观遗传修饰.
- 确定对衰老的新疗法目标至关重要.
研究的目的:
- 为了研究线粒体酸脱酶 (MDH2) 在衰老中的作用.
- 探索glibenclamide (Gli) 作为一种潜在的针对MDH2.2.的抗衰老治疗药物.
主要方法:
- 基于活动的蛋白质分析,以确定MDH2作为抗衰老的目标.
- 纤维细胞培养物以评估MDH2表达和衰老.
- 在自然衰老的小鼠体内研究,以评估Gli对寿命,脆弱性和肝脏健康的影响.
- 分析代谢途径,甲氨酸循环流量和组织素甲基化.
主要成果:
- MDH2表达与细胞衰老相关.
- Glibenclamide (Gli) 抑制了MDH2活性,减少了纤维细胞衰老,延长了小鼠的寿命,并减少了脆弱性.
- 肝脏特异性的MDH2敲击取消了Gli的好处,并减少了衰老标志物.
- 抑制MDH2干扰了中央碳代谢,增强了甲氨酸循环流动,并促进了组织素甲基化,特别是H3K27三甲基化.
结论:
- MDH2是通过代谢-表观遗传途径衰老的关键调节者.
- 通过像Gli这样的化合物来抑制MDH2代表了抗衰老干预的有前途的战略.
- 这项研究阐明了线粒体代谢,表观遗传修饰和衰老过程之间的联系.
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
158
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
158
01:06Oral Hypoglycemic Agents: Glinides
131
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
131
01:23Dipeptidyl Peptidase 4 Inhibitors
164
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
164
01:24Glucagon-like Receptor Agonists
291
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
291
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
144
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
144
01:22Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K